<DOC>
	<DOCNO>NCT01379157</DOCNO>
	<brief_summary>Imipenem carbapenem antibacterial agent broad spectrum activity Gram-negative Gram-positive bacteria . This agent often use last line therapy highly resistant Gram negative bacillus nosocomial infection . In common beta-lactamase inhibitor , main pharmacokinetic/pharmacodynamic ( PK/PD ) index correlate therapeutic efficacy time concentration tissue serum MIC administration continuous infusion prefer mode administration maximize parameter . However , tropical country , stability carbapenem antibiotic important consideration consider continuous infusion . Therefore , prolonged infusion may useful mode administration maximize bactericidal activity . This study demonstrate stability imipenem clinical use room temperature tropical country .</brief_summary>
	<brief_title>Pharmacodynamics Study Imipenem Patients With Ventilator Associated Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Imipenem</mesh_term>
	<criteria>Patients age &gt; = 20 year Patients VAP Gram negative bacillus infection sensitive imipenem disk diffusion Patients document hypersensitivity imipenem carbapenems Patients estimate creatinine clearance &lt; = 60 ml/min Patients circulatory shock Patients pregnant</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Patients ventilator-associated pneumonia</keyword>
</DOC>